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Paediatric, invasive pneumococcal disease
in Switzerland, 1985-1994
Iwan Venetz, Kurt Schopfer, Kathrin Muhlemann and the Swiss Pneumococcal Study Group
Background Cost effective use of new vaccines against pneumococcal disease in children requires
detailed information about the local epidemiology of pneumococcal infections.
Methods Data on 393 culture-confirmed cases of invasive pneumococcal infection in children
(<17 years) hospitalized in Swiss paediatric clinics were collected retrospectively
for the years 1985-1994.
Results Meningitis (42%) was most frequent, followed by pneumonia (28%) and bacter-
aemia (26%). The overall annual incidence was 2.7 cases per 100 000 children
<17 years old and 11 cases per 100 000 children <2 years old. Annual incidence
rates were stable over the study period. Lethality was high for meningitis (8.6%)
and bacteraemia (8.9%). A history of basal skull fracture was reported in 3.3%
of children with pneumococcal meningitis. Residence in a rural region was asso-
ciated with an increased risk of pneumococcal infection (relative risk = 1.45, 95%
confidence interval: 1.01-2.00).
Conclusions Paediatric, invasive pneumococcal disease seems to be less frequent in Switzer-
land than in other European and non-European countries. This may be due to
differences in diagnostic strategies and lower frequency of risk factors such as the
use of day care. Children with a history of basal skull fracture are at increased risk
for pneumococcal meningitis. Further investigation of the association of invasive
pneumococcal infection with rural residence and the use of antibiotics for upper
respiratory tract infections might give new insight into the dynamics of Strepto-
coccus pneumoniae infection and the development of antibiotic resistance.
Keywords Streptococcus pneumoniae, epidemiology, surveillance, vaccine, Switzerland
Accepted 24 March 1998
Streptococcus pneumoniae is an important cause of meningitis,
pneumonia, bacteraemia and otitis media in young children.
The increasing spread of antibiotic resistance world-wide and
reports of increasing incidence trends of invasive pneumococcal
infections from some countries make prevention of invasive
pneumococcal disease a priority.' Available polysaccharide vac-
cines do not protect children <2 years of age, who are at high
risk of pneumococcal disease. However, new conjugated vac-
cines axe currently being evaluated in clinical studies. The cost
efficient use and postlicensure evaluation of such new vaccines
will need a detailed knowledge about the local epidemiology of
pneumococcal infections.
Pneumococcal infections are not reportable in Switzerland.
Here, we present the results from a 10-year retrospective surveil-
lance of culture-confirmed, invasive pneumococcal infections
in children <17 years of age residing in Switzerland. The
Institute of Medical Microbiology, University of Bern, Bern, Switzerland.
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tudy provides a baseline for a future, nationwide surveillance
programme and the planning of vaccination strategies.
Methods
Data on invasive pneumococcal infections were collected retro-
spectively for 1 January 1985 to 31 December 1994 from the
records of 37 paediatric clinics. These study hospitals represent
all paediatric clinics in Switzerland except for one teaching
hospital (Geneva) and four small primary care units.2 Cases
were all children < 17 years of age, hospitalized in any of the
study clinics for invasive pneumococcal infection and residing
in Switzerland at disease onset. Invasive pneumococcal infec-
tion was defined as a positive culture for Streptococcus pneumoniae
from a sterile site including blood, cerebrospinal fluid (CSF),
pleural fluid/biopsy, synovial or peritoneal fluid or a positive
specific antigen test from CSF. The diagnosis of meningitis was
based on the isolation of S. pneumoniae or a positive antigen test
from CSF. Pneumonia cases had characteristic clinical symptoms
and radiographic changes at admission and a positive culture
from blood or pleural fluid/biopsy. Cases with a positive blood
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Table 1 Annual incidence and age distribution of invasive pneumococcal infections in Swiss children, 1985-1994
Diagnosis
Meningitis
Pneumonia
Bacteraemia
Total3
No (%)
165 (42.0)
109 (27.7)
102 (26.0)
393 (100)
Median age
(months)
16
42
17
24
% of cases
less than!
< 2
55.8
27.8
62.7
49.1
ipecifled age (y)
< 5
71.5
66.7
84.3
73.3
Cases/y per 100 000
less than
< 2
5.64
1.61
3.60
10.98
specified age (y)
< 5
3.13
1.89
2.27
7.61
< 1 7
1.19
0.73
0.71
2.69
"Including four cases with a clinical manifestation of septic arthritis, osteomyelitis, cellulitis or cerebellar abscess and 10 cases with unknown clinical
presentation.
culture and no clinical focus were grouped as bacteraemia. Chil-
dren with a positive blood culture and upper respiratory tract
infection such as otitis media were also put into this category.
Cases were identified based on hospital statistics and clinical
microbiological records and only included after review of the
clinical chart done by the same investigator (IV). Sociodemo-
graphic and clinical characteristics were abstracted from
clinical charts using a standardized questionnaire. Population
data stratified by age (years), gender, and state were available
from the Swiss Federal Statistical Office for the years 1985, 1990
and 1993. The population of the state of Geneva was excluded
from the calculation of incidence rates, since no cases were
ascertained from this region. Stratification in urban and rural
areas was done according to the definition used by the Swiss
Federal Statistical Office. A Poisson distribution was assumed in
order to calculate 95% confidence intervals (CI) around incid-
ence estimates. Statistical comparison of median ages was
done with the Mann-Whitney test. Age-adjusted relative risk
estimates (RR) and CI were calculated using the statistical
software EGRET (SERC, Seattle, WA).
Results
During the 10-year study period 393 cases of invasive pneumo-
coccal infections were identified. Meningitis was the most
frequent diagnosis (42%), followed by pneumonia (28%) and
bacteraemia (26%). Peritonitis was diagnosed in three (0.8%)
patients and four cases presented with cellulitis, arthritis,
cerebellar abscess or osteomyelitis. The clinical diagnosis was
not known for 10 patients. 5. pneumoniae was isolated from
blood in 228 (58.1%) cases, from CSF in 154 (39.2%) cases,
and in seven (1.8%) cases from a pleural biopsy. On 11 (2.8%)
occasions the diagnosis of meningitis was based on specific anti-
gen test in the CSF. Three (0.8%) of the cases had simultaneous,
invasive Haemophilus influenzae infection. In an earlier study
on the epidemiology of invasive H. influenzae infections in the
same study population and using the same case ascertainment
strategy completeness of the data was estimated to be around
90%.2 This estimate was based on the proportion of cases listed
in microbiology records that were also identified by hospital
statistics in one teaching hospital.
Incidence rates for different age groups and clinical mani-
festations are given in Table 1. The overall annual inddence in
children <17 years old was 2.7 cases per 100 000 and in chil-
dren <2 years old 11 cases per 100 000. Almost half (49.1%) of
all invasive pneumococcal infections occurred below age 2 years.
The median age at pneumococcal pneumonia (42 months) was
significantly higher than for meningitis (16 months) or bacter-
aemia (17 months). Death occurred in 24 (6.1%) cases during
the acute stage of infection (first 3 weeks after admission).
Lethality for meningitis was 8.6%, for bacteraemia 8.8%, and
0.9% for pneumonia. Boys (n = 225) acquired invasive pneumo-
coccal disease more often than girls (n = 164; RR = 1.37,
CI : 1.01-1.69).
Invasive pneumococcal infections peaked in December and
January (25.2% of all cases; P < 0.001) and there was a second
peak between March and June (37.9% of all cases; P = 0.02)
(Figure 1). Apart from seasonal variations, the annual incidence
rates overall and for the different clinical manifestations did not
show a significant time trend over the study period (data not
shown).
Twenty-eight cases (7.1%) had a known predisposing con-
dition: splenectomy due to hereditary spherocytosis (n = 1),
malignancy (n = 7), human immunodeficiency virus (HTV)
infection (n = 2), immunodeficiency (n = 5), or skull fracture
(n = 13). Thirteen children (3.3%) had two and one child
(0.3%) had three episodes of invasive pneumococcal infections
during the study period. Meningitis was the clinical mani-
festation in nine of the children with two episodes and the
one child with three infections. Pneumonia and bacteraemia
occurred twice in two children. The median age of the patients
at the time of the second or third episode was 5.5 years (range
12 months to 10 years). The interval between the first and sec-
ond episode ranged between 9 days and 7 years. Four children
had relapsing infection (interval <3 weeks) and 10 recurrent
episodes (interval >3 weeks). Two patients with repeated
meningitis had a history of basal skull fracture. No other pre-
disposing factors, such as asplenia, malignancies or FIIV
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Figure 1 Seasonal distribution of Invasive pneumococcal infections
among Swiss children, 1985-1994
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infection was present in any of the cases with more than
one episode.
Basai skull fracture was mentioned in the history of 13 cases
(3.3%), one of which had a known persisting traumatic CSF
fistula. The median interval between the head trauma and
infection was 11 months (range 0 days to 4 years; the time
interval was unknown for six cases) and the average at disease
was 7 years.
The incidence of invasive pneumococcal infection was higher
among children living in a rural region than among those living
in an urban area (annual incidence per 100 000: 3.15 for rural
regions and 2.70 for urban regions, RR = 1.38, CI: 1.12-1.70).
Also, the median age at disease onset was significantly higher in
children residing in rural regions (30 months) than in children
in urban areas (20.5 months; Mann-Whitney test P < 0.05).
Children of non-Swiss nationality had a significantly higher
rate of pneumococcal pneumonia between the age of 2 and
4 years than Swiss children (annual incidence per 100 000:
in non-Swiss 2.11, in Swiss 1.34, RR = 2.11, CI: 1.01^.36).
Also, non-Swiss children had pneumococcal pneumonia at a
significantly younger age (34 months) than Swiss children
(47 months; Mann-Whitney test P = 0.02). The frequency of
meningitis and bacteraemia was not significantly different for
Swiss and non-Swiss children (data not shown).
Discussion
This study investigated the epidemiology of invasive pneumo-
coccal infection in Swiss children between the years 1985 and
1994 in order to establish a baseline for a nationwide surveil-
lance programme and the planning of vaccination strategies
against S. pneumoniae. The overall incidence of invasive, paedi-
atric pneumococcal infection was lower than that reported
from other European and non-European countries. For example,
estimated annual incidence rates per 100 000 children <2 years
old were 26 in Sweden, 45 in Finland, 104 in Israel, 145 in
California, USA and 1195 in Alaska.4"8 The considerably higher
rate of bacteraemias observed in other countries might explain
some of these differences. For example, in Finland and Israel the
proportion of bacteraemia among invasive pneumococcal infec-
tion was 69% and 37%, respectively, as compared to 26% in
Switzerland.5'6 Finnish paediatricians have been encouraged
to take blood cultures, which leads to a higher proportion of
diagnosed bacteraemias.5 Also, it might be that in Switzerland
children with pneumococcal pneumonia or bacteraemia are more
often treated as outpatients due to their higher age at disease
than in other countries. The incidence rates for pneumococcal
meningitis are similar in Switzerland and in Finland. Factors
that might also contribute to a comparably low incidence of
invasive pneumococcal infections in Swiss children are the
infrequent use of day care and less crowding.9'10 Other non-
specific risk factors such as nutrition are less likely to play a
role due to the uniformly high living standard in Switzerland.
The higher age at infection in Swiss children indicates lower
exposure to 5. pneumoniae. In most other countries or popula-
tions the proportion of infections below age 2 years is higher
than 50%, e.g. in Sweden, Finland, the US, and Alaskan
Natives.4'5'7'8
By restricting this study to hospitalized cases the overall num-
ber of invasive and non-invasive infections that might possibly
be prevented by an efficient vaccine has been underestimated.
Reliable assessment of pneumococcal pneumonia and bacter-
aemia and otitis media in outpatients over time is difficult.
Therefore, in Switzerland and probably in other countries the
surveillance of pneumococcal disease must be based on incid-
ence trends of invasive infections that require hospitalization.
However, increased awareness and more frequent diagnostic
work up of pneumococcal infections makes such a surveillance
strategy susceptible to reporting bias.
This study could not provide data on the distribution of
pneumococcal serotypes causing invasive paediatric disease,
since S. pneumoniae isolates are not routinely typed in Switzer-
land. Based on the results from a recent Swiss multicentre study
on antibiotic resistance and serotype distribution of 5. pneumoniae
about 90% of invasive strains are covered by the currently used
23-valent polysaccharide vaccine.11 A conjugate vaccine in-
cluding the six most common serotypes would cover 61% of
invasive isolates in Switzerland. This is lower than estimated for
Finland.5
Interestingly, invasive pneumococcal infections were more
frequent in rural than urban areas of Switzerland. This correlates
with a higher frequency of invasive H. influenzae infections in
rural areas, which we found in an earlier study (Miihlemann,
unpublished data). This observation is unlikely to be due to a
diagnostic or reporting bias, since access to health care is gen-
erally high. The higher age at disease in rural cases suggests that
exposure to pneumococcus is less frequent or intense in rural
than urban regions. In fact, factors that promote exposure such
as high population density, use of public transportation, day care
usage etc. are more frequent in urban than rural areas. How-
ever, one might then expect a lower and not a higher incidence
of disease in rural children. It might be that children in urban
areas are treated more frequently with antibiotics for upper
respiratory tract infection and might therefore get some pro-
tection from invasive infection despite higher exposure. This
might promote antibiotic resistance of S. pneumoniae among the
urban population. We have currently no data to support this
hypothesis. Further investigation of the association of invasive
pneumococcal infection with rural residence and the use of
antibiotics for upper respiratory tract infections might give new
insight into the dynamics of S. pneumoniae infection and the
development of antibiotic resistance.12
Data on the frequency of repeated pneumococcal infections
are scarce in the literature.13 In our study the number of chil-
dren with more than one invasive episode was surprisingly
high. Especially, meningitis was more frequent than in earlier
reports.5 '1314 Our patients less often had a known predisposing
condition and they were on the average older. It might be that
a relatively long observation time and a relatively low pro-
portion of bacteraemia in our study population can explain
some of the differences.
Skull fracture is a known risk factor for bacterial meningitis.13
However, data on the incidence of meningitis after skull fracture
are scarce and vary between 0 and 36%. I 3 Among our patients,
3.3% had a history of basal skull fracture. To our knowledge
there are no data available about the ability of the available
pneumococcal vaccines to protect from meningitis after skull
fracture. The pathogenesis of such a meningitis may not involve
bacteraemia but proceed directly from the colonized upper
respiratory tract. Only conjugated pneumococcal vaccines (once
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available) might therefore have the potential to lower the risk
of meningitis after skull fracture by reducing nasopharyngeal
carriage of S. pneunwmae 15
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